News
J&J gets FDA okay for psoriasis drug icotrokinra
Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.
News
First MHRA/NICE aligned guidance due in June
The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.
News
US judge rules Kennedy's vaccine changes 'unlawful'
A US judge has stymied attempts by HHS Secretary Kennedy to change immunisation policy, stopping this week's vaccine advisory panel from going ahead.
News
AZ piles pressure on MSD et al in gastric cancer
AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.
News
GSK's RSV shot cleared in US for all adults
GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
